Physician profile
Steven Su
NPI 1417574633
$3,082.74
in general payments reported to CMS, 2019-2025
9 companies · $761 in 2025
The $761 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.62 · 2022: $70.98 · 2023: $378 · 2024: $1,825 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662 · Travel and Lodging: $1,113 · Entertainment: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.25 |
| Travel and Lodging | $1,113.22 |
| Entertainment | $188.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,655.16 | 2022-2024 | Precision 1, Total30, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $273.06 | 2023-2025 | Acuvue |
| Dompe US, INC. | $251.46 | 2025 | Oxervate |
| Glaukos Corporation | $242.42 | 2021-2023 | |
| Coopervision INC. | $217.58 | 2023-2025 | Ortho-K Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $188.67 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $124.99 | 2025 | Infuse |
| Lkc Technologies, INC. | $111.30 | 2024 | |
| Sight Sciences, INC. | $18.10 | 2023 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.